Arbutus Biopharma Corp (ABUS)

Last Year

23-Nov-23 -- 22-Nov-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Strong Sell

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

6

0

5

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
05-Feb-24 7:54 PM View:	02-Feb-24 Sale (Planned) ($23.08K)	Sofia Michael J. Chief Scientific Officer		Arbutus Biopharma Corp - ABUS	6% 1.55M to 1.65M	0	0	--	--	Show Txns Hide Txns

05-Feb-24 7:54 PM View:	02-Feb-24 Sale (Planned) ($22.18K)	Hastings David C Chief Financial Officer		Arbutus Biopharma Corp - ABUS	130% 79.0K to 181.91K	0	0	--	--	Show Txns Hide Txns

05-Feb-24 7:55 PM View:	01-Feb-24 Grant 0	Naftzger J. Christopher General Counsel and CCO		Arbutus Biopharma Corp - ABUS	100% 0 to 95.1K	0	0	--	--	Show Txns Hide Txns

05-Feb-24 7:55 PM View:	02-Feb-24 Sale (Planned) ($10.08K)	Sims Karen Chief Medical Officer		Arbutus Biopharma Corp - ABUS	334% 28.9K to 125.54K	0	0	--	--	Show Txns Hide Txns

05-Feb-24 7:54 PM View:	02-Feb-24 Sale (Planned) ($23.50K)	McElhaugh Michael J. Interim President & CEO Director		Arbutus Biopharma Corp - ABUS	8% 1.39M to 1.5M	0	0	--	--	Show Txns Hide Txns